Skip to content

Venture

LOGO 4-01

Affiliations

Rockefeller University

Weill Cornell Medical College

Technologies

Research Tool

Indication

Basic Research

Drug Discovery

Genetics & Genomics

Infectious Disease

Molecular Diagnostic

Additional Information

Women Founded

We will provide bacterial genome editing services using CRISPR-Cas technologies for academic and industrial customers interested in improving human health and developing bacterial technologies.

Team:
Wenyan Jiang – CEO, CSO
Yuchen Qi – Business Development